2023. A Randomized, Double-Blind, Placebo-Controlled Study On Evaluation Of Safety And Efficacy Of Niruryadi Gulika Ayurvadic Therapy In Type Ii Diabetic Neuropathy Patients. Journal of Pharmaceutical Negative Results. (Feb. 2023), 1269–1275. DOI:https://doi.org/10.47750/pnr.2023.14.S01.172.